Repurposed drug may extend survival in aggressive ovarian cancer, trial shows pred 23 urami in 53 minutami Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant casesA drug originally used to treat a rare disease could extend the lives of patients with an aggressive form of ovarian cancer, according to a clinical trial.Platinum-resistant ovarian cancer occurs when the disease progresses within six months of starting platinum-based chemotherapy. This form of chemotherapy is different from other types because it uses compounds that contain platinum to destroy cancer cells by preventing them from dividing. Continue reading...(The Guardian)
Fury as jockey who rode horse to £67,000 victory before it was put down after breaking back following a fall at Grand National Festival AVOIDS punishment
'I'm not playing the victim,' claims shamed former Scotland rugby captain Stuart Hogg in social media rant
Daughter of American woman missing in the Bahamas fears her stepdad will NEVER be charged, boyfriend claims
Grey's Anatomy may have turned me into a global superstar... but it took 15 years to become an overnight success!